中西醫(yī)結(jié)合治療90例反流性食管炎的臨床療效觀察

打開文本圖片集

摘 要 目的：觀察西醫(yī)聯(lián)合中藥協(xié)定方治療反流性食管炎患者的臨床療效。方法：將90例反流性食管炎患者隨機(jī)分成研究組和對(duì)照組，各45例。對(duì)照組予以奧美拉唑、莫沙必利、鋁碳酸鎂片3種藥物進(jìn)行聯(lián)合用藥治療，研究組則在對(duì)照組患者的治療基礎(chǔ)上給予中藥協(xié)定方（加味左金丸）進(jìn)行治療，比較兩組的臨床療效。結(jié)果：研究組中醫(yī)癥狀評(píng)分、不良反應(yīng)發(fā)生率低于對(duì)照組；總有效率高于對(duì)照組（P

關(guān)鍵詞 反流性食管炎 中西醫(yī)結(jié)合 加味左金丸 臨床療效

中圖分類號(hào)：R289.5； R259 文獻(xiàn)標(biāo)志碼：A 文章編號(hào)：1006-1533（2023）07-0022-03

引用本文 謝燕， 茅靖. 中西醫(yī)結(jié)合治療90例反流性食管炎的臨床療效觀察[J]. 上海醫(yī)藥， 2023， 44（7）： 22-24.

Clinical efficacy of the combination of Chinese and Western medicine in the treatment of 90 cases of reflux esophagitis

XIE Yan， MAO Jing

（Department of General Medicine， Songjiang Branch of Shuguang Hospital，

Shanghai University of Traditional Chinese Medicine， Shanghai 201600， China）

ABSTRACT Objective： To observe the clinical efficacy of Western medicine combined with herbal protocols in the treatment of patients with reflux esophagitis. Methods： Ninety patients with reflux esophagitis were randomly divided into a study group and a control group with 45 cases each. The control group was treated with a combination of three drugs， including omeprazole， mosapride and magnesium aluminum carbonate tablets， while the study group was treated with the traditional Chinese medicine prescription （Jiawei Zuojin pill） besides the therapy for the control group. The efficacy was compared between the two groups. Results： The traditional Chinese medical syndrome score and the incidence of adverse events were lower， and the overall efficacy was higher in the study group than the control group （P

KEY WORDS reflux esophagitis； combination of traditional Chinese and Western medicine； Jiawei Zuojin pill； clinical efficacy

反流性食管炎是最常見的胃腸道疾病之一，定義為“胃內(nèi)容物不正常反流至食管引起的慢性癥狀或黏膜損傷”。（剩余4373字）